Isothermal Nucleic Acid Amplification Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global isothermal nucleic acid amplification technology market was valued at $5 billion in 2024. Fueled by rising infectious illnesses, the technology is gaining traction as a reliable molecular diagnostic method, set to reach $12.5 billion by 2031. Increased concerns about antibiotic resistance and a focus on mitigating contagious diseases in developing nations are driving this growth. Additionally, the technology's exponential use in checking transfused blood serum for potential pathogens contributes to its expanding market presence.

Factors Propelling the Global Isothermal Nucleic Acid Amplification Technology Market

The scarcity of heat cycling apparatus limits point-of-care applications for conventional amplification technologies like PCR. Isothermal amplification technologies, requiring less energy and enabling test incubation in portable battery-powered systems, fill this gap. The Covid-19 outbreak has intensified the demand for rapid and precise testing, driving market opportunities. The USFDA granted emergency use authorization for new INAAT-based COVID-19 testing toolkits, such as Grifols' Procleix SARS-CoV-2 assay and Lucira Health's Lucira CHECK-IT COVID-19 test kit. These strategic moves, anticipating future events, are poised to reinforce key market trends and opportunities.

Future Opportunities:

Boosted by increased funding from government and private healthcare organizations, rapid analytic tools, particularly isothermal nucleic acid amplification technology, are gaining wider adoption in the fight against infectious illnesses. Initiatives from organizations like CDC and NIH contribute to this trend. The industry's expansion is further facilitated by the enhanced capacity and automation of these technologies, allowing efficient processing of numerous samples in a short timeframe.

The global market for isothermal nucleic acid amplification technology instruments is on the rise, fueled by intensified R&D efforts creating innovative diagnostics for emerging infectious diseases, including COVID-19. Upgraded diagnostic devices with enhanced reliability, mobility, and efficiency are poised to reshape the market for INAAT equipment in communicable disease control.

As healthcare infrastructure improves, there's an anticipation of increased market penetration for isothermal nucleic acid amplification technology diagnostics. The growth will be supported by a parallel increase in the production of associated reagents over the projected timeframe.

Factors Hampering the Global Isothermal Nucleic Acid Amplification Technology Market Development

The legal framework governing the development and advancement of INAAT-based diagnostics and treatment methods is a significant obstacle hampering the market's potential. Low awareness among patients and unclear laws regarding INAAT-based diagnostics further constrains the marketing of INAAT solutions. Moreover, the absence of a robust compensation mechanism in industrialized countries, such as the United States, can significantly hinder consumers' purchasing power. These factors pose limitations on market expansion in the expected timeframe.

Country-wise Insights:

United States Leading Global INAAT Market:

The United States takes the lead in global isothermal nucleic acid amplification technology market growth, contributing nearly 40% of the global revenue. With a well-established research network, robust healthcare infrastructure, and increasing demand for nucleic acid amplification-based treatments, the U.S. held the largest market share. High per capita healthcare spending and a growing interest in point-of-care diagnostic techniques are expected to further drive market expansion.

Growth Opportunities in European Countries:

Europe, with its prevalence of chronic illnesses and a preference for isothermal amplification technology, holds a dominant position in the INAAT market. Germany, in particular, has a significant market share due to its aging population and focused healthcare systems. The World Bank predicts that Germany's aging population, with individuals over 65 years old constituting 22% in 2021, will contribute to a notable increase in age-related illnesses, enhancing future market prospects for efficient INAAT devices.

Japan's Lucrative INAAT Market Share:

Asia Pacific, especially Japan, is expected to be a lucrative market for isothermal nucleic acid amplification technology. However, domestic players need to address challenges, such as the complexity of INAAT device manufacturing, given strict regulatory rules from organizations like PMDA in Japan. Despite these challenges, Japan's market share is growing, contributing to the overall rapid growth of the Asia Pacific market for INAAT technology.

Key Companies Profiled

Alere, Inc.
bioMerieux SA
Eiken Chemical Co. Ltd
Hologic Inc.(Gen-Probe)
Lucigen
Meridian Bioscience, Inc.
Ustar Biotechnologies Ltd.
QIAGEN
Quidel Corporation
Thermo Fisher Scientific, Inc.
BD (Becton, Dickinson & Company)
OptiGene Limited

Key Segments Covered in the Isothermal Nucleic Acid Amplification Technology Industry Report

Isothermal Nucleic Acid Amplification Technology Industry by Product Type

Instruments
Reagent

Isothermal Nucleic Acid Amplification Technology Market by Technology

NASBA
HDA
LAMP
SDA
SPIA
NEAR
TMA
RCA
RPA

Isothermal Nucleic Acid Amplification Technology by Application

Blood Screening
Infectious Disease Diagnostics
Cancer
Others

Isothermal Nucleic Acid Amplification Technology Market by End User

Hospitals
Central & Reference Labs
Others

Isothermal Nucleic Acid Amplification Technology Market by Region

North America Market
Europe Market
Asia Pacific Market
Middle East & Africa Market
South America Market

1. Executive Summary

1.1. Global Isothermal Nucleic Acid Amplification Technology Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, 2018 - 2031

3.1. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Instruments
  - 3.1.1.2. Reagent
3.2. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. NASBA
  - 3.2.1.2. HDA
  - 3.2.1.3. LAMP
  - 3.2.1.4. SDA
  - 3.2.1.5. SPIA
  - 3.2.1.6. NEAR
  - 3.2.1.7. TMA
  - 3.2.1.8. RCA
  - 3.2.1.9. RPA
  - 3.2.1.10. SMAP2
  - 3.2.1.11. Others
3.3. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Blood Screening
  - 3.3.1.2. Infectious Disease Diagnostics
  - 3.3.1.3. Cancer
  - 3.3.1.4. Others
3.4. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Blood Screening
  - 3.4.1.2. Infectious Disease Diagnostics
  - 3.4.1.3. Cancer
  - 3.4.1.4. Others
3.5. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, 2018 - 2031

4.1. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Instruments
  - 4.1.1.2. Reagent
4.2. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. NASBA
  - 4.2.1.2. HDA
  - 4.2.1.3. LAMP
  - 4.2.1.4. SDA
  - 4.2.1.5. SPIA
  - 4.2.1.6. NEAR
  - 4.2.1.7. TMA
  - 4.2.1.8. RCA
  - 4.2.1.9. RPA
  - 4.2.1.10. SMAP2
  - 4.2.1.11. Others
4.3. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Blood Screening
  - 4.3.1.2. Infectious Disease Diagnostics
  - 4.3.1.3. Cancer
  - 4.3.1.4. Others
4.4. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Blood Screening
  - 4.4.1.2. Infectious Disease Diagnostics
  - 4.4.1.3. Cancer
  - 4.4.1.4. Others
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.5.1.2. U.S. Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 4.5.1.3. U.S. Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.4. U.S. Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.5.1.5. Canada Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.5.1.6. Canada Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 4.5.1.7. Canada Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.8. Canada Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, 2018 - 2031

5.1. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Instruments
  - 5.1.1.2. Reagent
5.2. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. NASBA
  - 5.2.1.2. HDA
  - 5.2.1.3. LAMP
  - 5.2.1.4. SDA
  - 5.2.1.5. SPIA
  - 5.2.1.6. NEAR
  - 5.2.1.7. TMA
  - 5.2.1.8. RCA
  - 5.2.1.9. RPA
  - 5.2.1.10. SMAP2
  - 5.2.1.11. Others
5.3. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Blood Screening
  - 5.3.1.2. Infectious Disease Diagnostics
  - 5.3.1.3. Cancer
  - 5.3.1.4. Others
5.4. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Blood Screening
  - 5.4.1.2. Infectious Disease Diagnostics
  - 5.4.1.3. Cancer
  - 5.4.1.4. Others
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.2. Germany Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.3. Germany Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.4. Germany Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.5. U.K. Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.6. U.K. Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.7. U.K. Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.8. U.K. Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.9. France Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.10. France Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.11. France Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.12. France Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.13. Italy Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.14. Italy Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.15. Italy Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.16. Italy Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.17. Turkey Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.18. Turkey Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.19. Turkey Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.20. Turkey Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.21. Russia Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.22. Russia Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.23. Russia Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.24. Russia Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, 2018 - 2031

6.1. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Instruments
  - 6.1.1.2. Reagent
6.2. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. NASBA
  - 6.2.1.2. HDA
  - 6.2.1.3. LAMP
  - 6.2.1.4. SDA
  - 6.2.1.5. SPIA
  - 6.2.1.6. NEAR
  - 6.2.1.7. TMA
  - 6.2.1.8. RCA
  - 6.2.1.9. RPA
  - 6.2.1.10. SMAP2
  - 6.2.1.11. Others
6.3. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Blood Screening
  - 6.3.1.2. Infectious Disease Diagnostics
  - 6.3.1.3. Cancer
  - 6.3.1.4. Others
6.4. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Blood Screening
  - 6.4.1.2. Infectious Disease Diagnostics
  - 6.4.1.3. Cancer
  - 6.4.1.4. Others
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.2. China Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.3. China Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.4. China Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.5. Japan Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.6. Japan Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.7. Japan Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.8. Japan Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.9. South Korea Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.10. South Korea Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.11. South Korea Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.12. South Korea Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.13. India Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.14. India Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.15. India Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.16. India Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, 2018 - 2031

7.1. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Instruments
  - 7.1.1.2. Reagent
7.2. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
7.3. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Blood Screening
  - 7.3.1.2. Infectious Disease Diagnostics
  - 7.3.1.3. Cancer
  - 7.3.1.4. Others
7.4. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Blood Screening
  - 7.4.1.2. Infectious Disease Diagnostics
  - 7.4.1.3. Cancer
  - 7.4.1.4. Others
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.5.1.2. Brazil Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.3. Brazil Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.4. Brazil Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.5. Mexico Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.5.1.6. Mexico Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.7. Mexico Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.8. Mexico Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.9. Argentina Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.5.1.10. Argentina Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.11. Argentina Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.12. Argentina Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, 2018 - 2031

8.1. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Instruments
  - 8.1.1.2. Reagent
8.2. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. NASBA
  - 8.2.1.2. HDA
  - 8.2.1.3. LAMP
  - 8.2.1.4. SDA
  - 8.2.1.5. SPIA
  - 8.2.1.6. NEAR
  - 8.2.1.7. TMA
  - 8.2.1.8. RCA
  - 8.2.1.9. RPA
  - 8.2.1.10. SMAP2
  - 8.2.1.11. Others
8.3. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Blood Screening
  - 8.3.1.2. Infectious Disease Diagnostics
  - 8.3.1.3. Cancer
  - 8.3.1.4. Others
8.4. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Blood Screening
  - 8.4.1.2. Infectious Disease Diagnostics
  - 8.4.1.3. Cancer
  - 8.4.1.4. Others
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.2. GCC Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.3. GCC Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.4. GCC Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.5. South Africa Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.6. South Africa Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.7. South Africa Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.8. South Africa Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.9. Egypt Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.10. Egypt Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.11. Egypt Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.12. Egypt Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.13. Nigeria Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.14. Nigeria Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.15. Nigeria Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.16. Nigeria Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product vs Application Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Alere, Inc.
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. bioMerieux SA
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Eiken Chemical Co. Ltd
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Hologic Inc.(Gen-Probe)
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Lucigen
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Meridian Bioscience, Inc.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Ustar Biotechnologies Ltd.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. QIAGEN
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Quidel Corporation
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations